Sonoma Pharmaceuticals (SNOA) Other Non Operating Income (2010 - 2020)
Sonoma Pharmaceuticals (SNOA) posted quarterly Other Non Operating Income of $234000.0 for Q1 2020, up 73.33% year-over-year from $135000.0 in Q2 2019, and up 274.63% quarter-over-quarter from -$134000.0 in Q4 2019.
Sonoma Pharmaceuticals (SNOA) Other Non Operating Income (2010 - 2020) Analysis & Trends
Sonoma Pharmaceuticals' Other Non Operating Income history runs 11 years deep, the most recent figure standing at $234000.0 for Q1 2020.
- In Q1 2020, Other Non Operating Income rose 73.33% year-over-year to $234000.0; the TTM figure through Mar 2020 stood at $257000.0 (up 25800.0% YoY), while the FY2022 annual figure was $723000.0, changed N/A from the prior year.
- Other Non Operating Income for Q1 2020 stood at $234000.0, up from -$134000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $234000.0 in Q1 2020, with the low at -$158000.0 in Q1 2017.
- The 5-year median for Other Non Operating Income is $3000.0 (2016), against an average of $13142.9.
- The sharpest annual moves came in 2016 and 2017: Other Non Operating Income soared 105.08% in 2016, then slumped 1480.0% in 2017.
- Sonoma Pharmaceuticals' Other Non Operating Income stood at $3000.0 in 2016, then plunged by 5366.67% to -$158000.0 in 2017, then surged by 113.92% to $22000.0 in 2018, then sank by 709.09% to -$134000.0 in 2019, then jumped by 274.63% to $234000.0 in 2020.
- Business Quant data shows SNOA's Other Non Operating Income at $234000.0 in Q1 2020, -$134000.0 in Q4 2019, and $135000.0 in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Sonoma Pharmaceuticals | 5.19 Mn | -145,899.91 | 2.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 234,000.00 |
| Dec 31, 2019 | -134,000.00 |
| Mar 31, 2019 | 135,000.00 |
| Dec 31, 2018 | 22,000.00 |
| Mar 31, 2017 | -158,000.00 |
| Jun 30, 2016 | 3,000.00 |
| Mar 31, 2016 | -10,000.00 |
| Dec 31, 2015 | 4,000.00 |
| Sep 30, 2015 | 65,000.00 |
| Jun 30, 2015 | -59,000.00 |
| Mar 31, 2015 | 166,000.00 |
| Dec 31, 2014 | 5,000.00 |
| Sep 30, 2014 | -14,000.00 |
| Jun 30, 2014 | 1.48 Mn |
| Mar 31, 2013 | 1,000.00 |
| Dec 31, 2012 | -84,000.00 |
| Sep 30, 2012 | -397,000.00 |
| Jun 30, 2012 | 1.25 Mn |
| Mar 31, 2012 | -21,000.00 |
| Dec 31, 2011 | 86,000.00 |